The initial dosage of Ipamorelin is often lower to allow the body to adjust, with increments made based on individual responses
While most blame their willpower, stress and low GLP-1 levels can cause hormonal imbalances that drive late-night hunger
[3] Some people experience gastrointestinal upset, such as nausea, stomach cramps, or diarrhea, especially when they first start the medication
Many people notice that what once felt like complete appetite quiet now feels like a soft buzzor even a return to old cravings
Food and Drug Administration (FDA) approval in May 2022 for type 2 diabetes, November 2023 for chronic weight management, and December 2024 for obstructive sleep apnea, marking it as the first approved therapy for this indication